Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Male patients between 45 and 80 years old who are already scheduled to have a prostate MRI scan followed by a prostate biopsy as part of their normal medical care
- Patients who have signed a consent form agreeing to take part in the trial
Who may not be able to join:
- Patients who have had any prostate treatment in the past 5 years, such as surgery, freezing therapy, heat therapy, radiation, or similar procedures
- Patients who currently have an active urinary tract infection
- Patients who are taking a type of medication called 5-alpha reductase inhibitors (a drug sometimes used for prostate or hair loss conditions — confirm with trial site if unsure whether this applies)
- Patients whose MRI scan was done at a location other than Kantonsspital Aarau
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Sensitivity and specificity of the Proclarix risk score detenging clinically relevant prostate cancer.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.